William Blair Downgrades Anadys Pharmaceuticals (ANDS) to Market Perform
Tweet
Share
E-mailGet Alerts ANDS Hot Sheet
Price: $3.70 --0%
Rating Summary:
0 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Rating Summary:
0 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Join SI Premium – FREE
William Blair downgraded Anadys Pharmaceuticals (NASDAQ: ANDS) from Outperfrom to Market Perform, maintains price target of $4.00.
For an analyst ratings summary and ratings history on Anadys Pharmaceuticals click here. For more ratings news on Anadys Pharmaceuticals click here.
Shares of Anadys Pharmaceuticals closed at $3.64 yesterday.
For an analyst ratings summary and ratings history on Anadys Pharmaceuticals click here. For more ratings news on Anadys Pharmaceuticals click here.
Shares of Anadys Pharmaceuticals closed at $3.64 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Piper Sandler Double Downgrades Myriad Genetics (MYGN) to Underweight, 'Major Strategic Action Likely Needed'
- JPMorgan Downgrades Industrial Bank Co Ltd (601166:CH) to Neutral
- UBS Downgrades H.U. Group Holdings Inc (4544:JP) to Neutral
Create E-mail Alert Related Categories
DowngradesRelated Entities
William BlairSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
